Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
National

Possible Skin Cancer Vaccine Shows Promise In Late Stage Trial. Moderna Stock Skyrockets.

Moderna announces positive results on groundbreaking cancer treatment. (Credit: Reuters)

News of a potential personalized cancer vaccine more than doubled the value of Moderna's stock Wednesday.

Moderna and Merck jointly announced Wednesday that a late-stage trial produced positive results, CNBC reported. According to the network, the mRNA-based shot combined with Merck's immunotherapy Keytruda hit goals in the third phase of a drug trial that involved 1,100 patients.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.